
No Increased Neurodevelopmental Risk in Children of Fathers Treated with Valproate: JAMA
A new analysis published in JAMA Network Open has revealed that children whose fathers were treated with valproate during spermatogenesis did not show an increased risk of neurodevelopmental disorders. This finding challenges earlier data from IQVIA, which …